- Home
- BGLC vs NTBL Comparison
BGLC vs NTBL Comparison
Compare BGLC & NTBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BGLC
- NTBL
- Stock Information
- Founded
- BGLC 2017
- NTBL 2000
- Country
- BGLC Malaysia
- NTBL United States
- Employees
- BGLC N/A
- NTBL N/A
- Industry
- BGLC Medical Specialities
- NTBL Biotechnology: Pharmaceutical Preparations
- Sector
- BGLC Health Care
- NTBL Health Care
- Exchange
- BGLC Nasdaq
- NTBL Nasdaq
- Market Cap
- BGLC 7.6M
- NTBL 4.6M
- IPO Year
- BGLC N/A
- NTBL N/A
- Fundamental
- Price
- BGLC $0.37
- NTBL $0.34
- Analyst Decision
- BGLC
- NTBL Buy
- Analyst Count
- BGLC 0
- NTBL 2
- Target Price
- BGLC N/A
- NTBL $5.00
- AVG Volume (30 Days)
- BGLC 117.9K
- NTBL 8.0M
- Earning Date
- BGLC 11-20-2024
- NTBL 11-12-2024
- Dividend Yield
- BGLC N/A
- NTBL N/A
- EPS Growth
- BGLC N/A
- NTBL N/A
- EPS
- BGLC N/A
- NTBL N/A
- Revenue
- BGLC $9,183,168.00
- NTBL $313,000.00
- Revenue This Year
- BGLC N/A
- NTBL N/A
- Revenue Next Year
- BGLC N/A
- NTBL N/A
- P/E Ratio
- BGLC N/A
- NTBL N/A
- Revenue Growth
- BGLC N/A
- NTBL 3812.50
- 52 Week Low
- BGLC $0.31
- NTBL $0.22
- 52 Week High
- BGLC $3.39
- NTBL $4.24
- Technical
- Relative Strength Index (RSI)
- BGLC 32.80
- NTBL 43.04
- Support Level
- BGLC $0.38
- NTBL $0.28
- Resistance Level
- BGLC $0.49
- NTBL $0.67
- Average True Range (ATR)
- BGLC 0.02
- NTBL 0.06
- MACD
- BGLC -0.01
- NTBL -0.00
- Stochastic Oscillator
- BGLC 5.94
- NTBL 27.53
About BGLC BioNexus Gene Lab Corp Common stock
BioNexus Gene Lab Corp through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of 11 different diseases.
About NTBL Notable Labs Ltd.
Notable Labs Ltd is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), Notable bio-simulates a cancer treatment to predict whether or not a patient is likely to respond to that specific therapeutic. PPMP is designed to enable Notable to identify and select patients expected to be clinically responsive before the initiation of their treatment and potentially enable fast-track therapeutic development in this patient population.